{
  "pmcid": "10959252",
  "sha256": "5c08d49d854bf931767ae79321c7d995b61b7967e6bff7b3f23ffa8c12f7ba06",
  "timestamp_utc": "2025-11-09T15:13:31.652645+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.16129411764706,
    "reading_ease": 12.5565294117647,
    "word_count": 250
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Twenty subjects with biopsy proven pulmonary adenocarcinomas were enrolled in a Phase I clinical trial"
      },
      "Participants": {
        "score": 1,
        "evidence": "Twenty subjects with biopsy proven pulmonary adenocarcinomas"
      },
      "Intervention": {
        "score": 2,
        "evidence": "to test the safety and feasibility of OTL38, a novel folate receptor-α (FRα) targeted optical contrast agent"
      },
      "Objective": {
        "score": 1,
        "evidence": "We hypothesize that folate receptor-targeted intraoperative molecular imagining can be safe and improve localization of pulmonary nodules during resection."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Twenty subjects with biopsy proven pulmonary adenocarcinomas"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Of the 20 subjects, three Grade I adverse events were observed"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Sixteen of 20 (80%) of subjects had tumors with in situ fluorescence with a mean tumor-to-background fluorescence level of 2.9 (IQR, 2.1 to 4.2)."
      },
      "Harms": {
        "score": 1,
        "evidence": "three Grade I adverse events were observed: all transient nausea/abdominal pain"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}